Autolus Therapeutics (AUTL) Equity Ratio (2017 - 2025)

Autolus Therapeutics (AUTL) has 9 years of Equity Ratio data on file, last reported at 0.3 in Q4 2025.

• For the quarter ending Q4 2025, Equity Ratio fell 44.61% year-over-year to 0.3; the trailing twelve-month figure through Dec 2025 stood at 0.3 (down 44.61% YoY), and the FY2025 full-year result was 0.3, down 44.61% from the prior year.
• Equity Ratio for Q4 2025 stood at 0.3, down from 0.4 in the prior quarter.
• Across five years, Equity Ratio topped out at 0.86 in Q2 2021 and bottomed at 0.3 in Q4 2023.
• The 5-year median for Equity Ratio is 0.59 (2022), against an average of 0.59.
• The widest annual swing landed in 2023, when Equity Ratio plunged 51.25%; it then soared 83.84% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.77 in 2021, then declined by 21.15% to 0.61 in 2022, then slumped by 51.25% to 0.3 in 2023, then jumped by 83.84% to 0.55 in 2024, then tumbled by 44.61% to 0.3 in 2025.
• The last three Equity Ratio figures came in at 0.3 (Q4 2025), 0.4 (Q3 2025), and 0.48 (Q2 2025), per Business Quant data.

Peer Comparison